Skip to content

Clinical evaluation of Heling Soothing moisturizing repairing cream combined with Desonide cream in the treatment of children with atopic dermatitis

Clinical evaluation of Heling Soothing moisturizing repairing cream combined with Desonide cream in the treatment of children with atopic dermatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074553
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Heling Soothing moisturizing repairing cream+ desonide cream group:N/A
desonide cream group:N/A

Sponsors

Zhongshan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 16 Years

Inclusion criteria

Inclusion criteria: (1) Meet the necessary indicators in Williams diagnostic criteria; (Meet 3 major criteria or more than 3 minor criteria) Main criteria: skin itching; Secondary criteria: 1) History of flexor involvement, including cubital fossa, popliteal fossa, ankle, and neck (including buccal rash in children under 10 years of age); 2) History of allergic rhinitis or asthma (or history of atopic disease in first-degree relatives of children under 4 years of age); 3) Recent history of dryness of the whole body skin; 4) A history of flexion eczema (cheek/forehead and limb extension eczema in children under 4 years of age); 5) Onset before 2 years old (for patients older than 4 years old) (2) Obtain informed consent and adhere to follow-up until the end.

Exclusion criteria

Exclusion criteria: (1) Allergic to desonide or Heling Soothing moisturizing repairing cream; (2) those who received glucocorticoids and antihistamines before treatment (2 weeks); (3) The skin has serious erosion and exudation of lesions; (4) complicated with acute infection; (5) Unable to follow the doctor's advice and adhere to the follow-up.

Design outcomes

Primary

MeasureTime frame
Efficacy index;

Secondary

MeasureTime frame
EASI;NRS;POEM;DLQI;

Countries

China

Contacts

Public ContactLi Chen

Zhongshan People's Hospital

knoberlee@163.com+86 186 8688 3773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026